Finance

Lists
1ABBV:BIT
AbbVie Common Stock
€230,10
-0,60%
(-1,40) 1D
2 Okt., 17:26:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1ABBV...
Open
€232,20
High
€232,20
Low
€230,10
Mkt. cap
464,43 mjd
Avg. vol.
38,00
Volume
26,00
52-wk high
€234,90
52-wk low
€168,00
No. of employees
57 k
Open
€232,20
High
€232,20
Low
€230,10
Mkt. cap
464,43 mjd
Avg. vol.
38,00
Volume
26,00
52-wk high
€234,90
52-wk low
€168,00
No. of employees
57 k
News stories
From web sources and news partners
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues. The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 k
Founded10 Apr. 2012
HeadquartersNorth Chicago, Illinois, Verenigde State van Amerika
Sector-
Websiteabbvie.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
15,78 mjd
16,62 mjd
15,00 mjd
16,99 mjd
Cost of goods sold
4,46 mjd
4,55 mjd
4,22 mjd
4,29 mjd
Cost of revenue
4,46 mjd
4,55 mjd
4,22 mjd
4,29 mjd
Research and development expenses
2,29 mjd
2,58 mjd
2,47 mjd
2,34 mjd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,43 mjd
3,82 mjd
3,49 mjd
3,55 mjd
Operating expense
5,72 mjd
6,40 mjd
5,96 mjd
5,90 mjd
Total operating expenses
10,18 mjd
10,95 mjd
10,18 mjd
10,19 mjd
Operating income
5,60 mjd
5,67 mjd
4,82 mjd
6,80 mjd
Other non operating income
199,00 m
120,00 m
-3,00 m
-55,00 m
EBT including unusual items
714,00 m
2,67 mjd
1,04 mjd
4,28 mjd
EBT excluding unusual items
5,11 mjd
5,12 mjd
4,19 mjd
6,07 mjd
Income tax expense
526,00 m
853,00 m
342,00 m
662,00 m
Effective tax rate
73,67%
31,97%
32,92%
15,47%
Other operating expenses
-
-
-
-
Net income
186,00 m
1,82 mjd
695,00 m
3,61 mjd
Net profit margin
1,18%
10,93%
4,63%
21,27%
Earnings per share
1,86
2,71
2,65
3,65
Interest and investment income
72,00 m
59,00 m
72,00 m
67,00 m
Interest expense
-739,00 m
-714,00 m
-717,00 m
-746,00 m
Net interest expenses
-667,00 m
-655,00 m
-645,00 m
-679,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
7,66 mjd
7,66 mjd
6,76 mjd
8,68 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme